Dartmouth College

Dartmouth Digital Commons
Dartmouth Scholarship

Faculty Work

10-5-2009

Mast Cell–Derived Particles Deliver Peripheral Signals to Remote
Lymph Nodes
Christian A. Kunder
Duke University Medical Center

Ashley L. St. John
Duke University Medical Center

Guojie Li
Duke University Medical Center

Kam W. Leong
Duke University Medical Center

Brent Berwin
Dartmouth College

See next page for additional authors

Follow this and additional works at: https://digitalcommons.dartmouth.edu/facoa
Part of the Medical Sciences Commons

Dartmouth Digital Commons Citation
Kunder, Christian A.; St. John, Ashley L.; Li, Guojie; Leong, Kam W.; Berwin, Brent; Staats, Herman F.; and
Abraham, Soman N., "Mast Cell–Derived Particles Deliver Peripheral Signals to Remote Lymph Nodes"
(2009). Dartmouth Scholarship. 2908.
https://digitalcommons.dartmouth.edu/facoa/2908

This Article is brought to you for free and open access by the Faculty Work at Dartmouth Digital Commons. It has
been accepted for inclusion in Dartmouth Scholarship by an authorized administrator of Dartmouth Digital
Commons. For more information, please contact dartmouthdigitalcommons@groups.dartmouth.edu.

Authors
Christian A. Kunder, Ashley L. St. John, Guojie Li, Kam W. Leong, Brent Berwin, Herman F. Staats, and
Soman N. Abraham

This article is available at Dartmouth Digital Commons: https://digitalcommons.dartmouth.edu/facoa/2908

ARTICLE

Mast cell–derived particles deliver peripheral
signals to remote lymph nodes
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During infection, signals from the periphery are known to reach draining lymph nodes
(DLNs), but how these molecules, such as inflammatory cytokines, traverse the significant
distances involved without dilution or degradation remains unclear. We show that peripheral
mast cells, upon activation, release stable submicrometer heparin-based particles containing
tumor necrosis factor and other proteins. These complexes enter lymphatic vessels and
rapidly traffic to the DLNs. This physiological drug delivery system facilitates communication
between peripheral sites of inflammation and remote secondary lymphoid tissues.
CORRESPONDENCE
Soman N. Abraham:
soman.abraham@duke.edu
Abbreviations used: BMMC,
BM-derived MC; DLN, draining LN; HEV, high endothelial
venule; MC, mast cell; SEM,
scanning electron micrograph.

The draining LNs (DLNs) are dynamic lymphoid structures that coordinate the development
of specific immune responses after microbial
or vaccine challenge. In response to these peripheral events, the DLN quickly undergoes significant structural changes, including rapid growth
and vascular remodeling (McLachlan et al.,
2003; Soderberg et al., 2005). This enlargement,
which is largely attributable to enhanced recruitment and retention of naive lymphocytes
from the circulation, increases the probability
that rare lymphocytes bearing relevant specificities will be present to interact with activated tissue-derived APCs, which must migrate from
inflamed tissues via afferent lymphatic vessels.
This interaction between lymphocytes and
APCs occurring within DLNs is the critical initiating event in the development of the adaptive
immune response.
For these rapid and impressive changes in
DLNs to occur after microbial or vaccine challenge, not only should lymphocytes and APCs
be able to reach the DLN but, importantly,
LNs must receive signals from the periphery to
create the appropriate environment to facilitate
this interaction. It has been suggested that the
periphery signals the DLN by “remote control”
(Baekkevold et al., 2001; Palframan et al., 2001;
Huang et al., 2008). For example, a chemokine,
monocyte chemoattractant protein-1, has been
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suggested to drain via afferent lymphatics into
the DLN (Palframan et al., 2001). A potential
peripheral source of immunomodulatory mediators is the mast cell (MC), a cell type which is
strategically situated beneath epithelial barriers.
In addition to their presence at potential sites of
pathogen entry, MCs express numerous pattern
recognition and other receptors for rapidly
recognizing pathogens (Prodeus et al., 1997;
Malaviya et al., 1999; Supajatura et al., 2001), as
well as the capacity to release large amounts of
inflammatory mediators, many of which are
concentrated within prominent cytoplasmic
granules and are available for immediate release.
One such prestored mediator is TNF (Gordon
and Galli, 1990), a multifunctional cytokine
which is implicated in modulating immune cell
trafficking. Recent studies have shown that as
rapidly as 1 h after peripheral MC activation,
increased levels of TNF are detected in pre
nodal lymph (Frangogiannis et al., 1998) and in
the DLNs (McLachlan et al., 2003). The lack of
any corresponding change in DLN TNF message suggested that it was not newly synthesized
locally but was derived from peripheral sources
(McLachlan et al., 2003). Because a significant
period of time is required for the secretion of
de novo cytokine after stimulation, this peripheral
© 2009 Kunder et al. This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months
after the publication date (see http://www.jem.org/misc/terms.shtml). After six
months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at http://creativecommons.
org/licenses/by-nc-sa/3.0/).
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source appears to be preformed MC TNF, a conclusion supported by the finding that most MCs in the vicinity of infection were degranulated (McLachlan et al., 2003). One might
presume that TNF, secreted by peripheral MCs into the extracellular fluid, enters lymphatic vessels and then is carried to
DLNs as a soluble molecule in the lymph. However, considering the route of trafficking and the significant distances
involved, it is unclear how peripherally derived TNF could
reach the DLNs without degradation, dilution to ineffective
concentrations, or interaction with extracellular matrix components. This scenario is especially difficult to rationalize early
in the response when it is expected that only small amounts of
TNF are elaborated, and because TNF has a very short halflife in vivo (Rampart et al., 1989). This uncertainty is supported by the observation that although peripherally injected
chemokines can be detected in DLNs, it typically requires the
application of large quantities of recombinant protein (Stein
et al., 2000; Baekkevold et al., 2001).
One conceivable explanation for the long-distance action
of MC-derived TNF is its trafficking in a form resistant to
dilution and degradation. To investigate this possibility, we
examined the process of MC exocytosis in detail. When MCs
undergo secretory exocytosis of granules (degranulation), in
addition to releasing some prestored mediators as freely soluble molecules (e.g., histamine and -hexosaminidase), they
also release distinct insoluble granular particles, comprised
primarily of heparin proteoglycans and positively charged
proteases (Schwartz et al., 1981). Other than isolated studies
describing their uptake by phagocytic cells (Welsh and Geer,
1959; Miyata and Takaya, 1985), the fate of these particles
after MC degranulation is largely unknown. MC granule
particles are insoluble because of the large numbers of electrostatic interactions between the highly cationic MC-specific
proteases and highly anionic heparin proteoglycans (Schwartz
et al., 1981). Because heparin is also known to bind strongly
to a variety of extracellular signaling proteins (Roberts et al.,
1988; Webb et al., 1993), it is probable that some MC-derived
mediators are borne within the particle structure even after
their release. This possibility led us to hypothesize that MC
particles might function as extracellular chaperones for MC
mediators (e.g., TNF) in vivo, carrying these signaling molecules from the periphery to the DLN.
RESULTS
Activated MCs release stable particles containing
inflammatory mediators
First, we investigated whether MCs released stable particles
upon activation. Fig. 1 (A and B) shows scanning electron
micrographs (SEMs) of isolated rat peritoneal MCs before
and after 15 min of exposure to compound 48/80, a potent
small molecule MC activator. After MC activation, a large
number of extracellular spherical particles were dispersed
around each MC (Fig. 1 B), which had a mean diameter of
917 nm. Examination at higher magnification revealed that
each of these particles was comprised of many smaller, mostly
spherical, subunits with a mean diameter of 59.4 nm (Fig. 1 C).
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Video microscopy of these events revealed the dynamics of
particle release by MCs (Video 1). Interestingly, particles
were released relatively gradually and continued to be shed
for at least a minute after treatment.
To demonstrate the release of particles by MCs in vivo,
we injected the footpads of mice with compound 48/80 and,
30 min later, thin tissue sections were prepared and examined
for MC granule release. The granules were detected with Alexa
Fluor 488–conjugated avidin, a probe which selectively binds
heparin (Tharp et al., 1985), a major constituent of MC granules (Fig. 1, D and E). Also, when MCs were activated in vivo
with another more physiological stimulus, bacterial peptidoglycan, identical particles were released into the surrounding
tissue (unpublished data). This is consistent with the work of
others showing that the morphology of degranulation is not
highly dependent on the stimulus (Bloom and Chakravarty,
1970; Tizard and Holmes, 1974). Significant MC degranu
lation was observed in the footpad sections and extracellular
particles moved significant distances from their parent cells,
especially in areas of less dense connective tissue. Observations
revealed that 30 min after MC degranulation in vivo, morphologically distinct particles containing heparin could be
detectable in the immediate vicinity as well as at considerable
distances (up to 150 µm in this section) from the site of release.
Some of these extracellular particles were still detectable up to
one hour after treatment (unpublished data).
Next, we attempted to determine whether relevant signaling molecules were present in the particles released by
MCs. Recent evidence shows that TNF, like many other
immune molecules, binds to heparin (Kenig et al., 2008),
suggesting that it may be retained in the heparin-based particles after exocytosis. To investigate this, we purified MC
granule particles from rat peritoneal lavage cells using a modification of a previously described technique (Lindstedt et al.,
1992). In brief, the cells were treated with compound 48/80
and the released particles were isolated by differential centrifugation. Fig. 2 A shows a micrograph of a suspension of isolated MC-derived particles. The purified particles were very
stable after isolation, not changing appreciably in appearance
or protein composition even after 2 mo at room temperature.
To determine their bulk protein composition, we subjected
them to SDS-PAGE followed by SYPRO Ruby staining
(Fig. 2 B). The major bands between 25 and 37 kD correspond to the major rat MC proteases, as determined by a
proteomic analysis (unpublished data), which are known to
be the most abundant protein constituents of MC granules
(Lagunoff and Pritzl, 1976). We also used these preparations
to address whether signaling molecules, such as TNF, are
present in the particles as minor components. Because TNF
was shown in earlier studies to be relevant to morphological
changes in the DLNs (McLachlan et al., 2003), we were especially interested in the presence of this signaling molecule. An
anti-TNF immunoblot of purified granule remnant proteins
revealed a band that comigrated with recombinant rat TNF
(Fig. 2 C). The identity of this band was confirmed with two
additional different anti-TNF antibodies (unpublished data).
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Figure 1. MCs release insoluble heparin-containing particles. (A) SEM of an unstimulated rat peritoneal MC (rPMC). Bar, 2 µm. (B) SEM of rPMC
15 min after treatment with compound 48/80 at 5 µg/ml. Bar, 2 µm. (C) SEM of a single extracellular granule. Bar, 500 nm. Release of particles by rat peritoneal MCs was observed repeatedly (in greater than three independent experiments). SEMs are shown from one representative experiment. For some trials
(A–C), lavage was pooled from multiple rats to obtain sufficient material for analysis. (D) Confocal micrograph of MCs in mouse footpad (granule heparin
labeled with Alexa Fluor 488–conjugated avidin) 30 min after PBS injection showing undegranulated MCs. Bar, 30 µm. (E) Mouse footpad MCs surrounded by
extracellular particles 30 min after injection of 5 µg of compound 48/80. Bar, 30 µm. Release of particles in vivo was observed in greater than three independent experiments using groups of two to three mice each. Experiments are representative of data derived from greater than three animals.
JEM VOL. 206, October 26, 2009
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Figure 2. MC-derived particles contain preformed TNF. (A) Differential interference contrast micrograph of purified MC granule particles. (B) SYPRO
Ruby–stained SDS-PAGE gel of MC particle-associated proteins. (C) TNF immunoblot of SDS-PAGE–separated proteins from purified particles showing
detection of rat TNF. (D) A still image from Video 2 showing that particles released from RBL-2H3 cells after activation retain overexpressed TNF-GFP
fusion protein. Bars, 15 µm. White boxes highlight released particles with retained fluorescence. All panels depict data representative of experiments
performed more than three times, with trials using lavage from individual rats or pooled from multiple rats, for a total n > 3.
2458
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To further demonstrate the presence of TNF within released
MC-derived particles, we expressed a TNF-GFP fusion protein in the rat MC line RBL-2H3 and in mouse BM-derived
MCs (BMMCs) to follow the extracellular fate of preformed
TNF after degranulation. In both cases, the fusion protein
was clearly localized to vesicles, and it colocalized with
known granule markers (Fig. S1). After activation, both cell
types released free particles that retained their fluorescence
in the extracellular environment (Fig. 2 D and Videos
2 and 3). Although the particles released by the cells have not
been biochemically characterized, their origin in the granular compartment suggests that they are similar in nature to
those released by peritoneal MCs. These findings strongly
suggest that TNF released from activated MCs is not freely
soluble but remains associated with the granular heparin
matrix after exocytosis.
MC-derived particles drain to local LNs via lymphatics
In order for MC-derived particles to reach the DLN, they
must be able to enter lymphatic vessels. Unlike the vascular
endothelium, the endothelium of lymphatic capillaries is
highly permeable as a result of the presence of discontinuities
between individual endothelial cells. These gaps can be larger
than a micrometer in diameter and should readily admit objects the size of MC-derived particles (Leak, 1980; Trzewik
et al., 2001). Indeed, during edema (which occurs almost instantaneously after MC degranulation because of the rapid
action of the completely soluble mediator histamine on vascular permeability), these openings are enlarged as the relative quantity of bulk tissue flow entering the lymphatic system
is greatly increased (Casley-Smith, 1980). Thus, it is likely
that conditions in the tissue after MC activation favor the entry
of these particles into lymphatic vessels.
To visualize this process, we focused on the rat mesentery, because it was amenable to observation in whole mount,
allowing the entire lymphatic network and connective tissue
drainage to be visualized (Fig. 3 A). In mesentery isolated
30 min after the intraperitoneal instillation of compound 48/80,
extensive MC degranulation occurred, and clear colocalization between extracellular MC granule particles and lymphatic capillaries was observed along the length of lymphatic
vessels (Fig. 3, B and C). In contrast, there was little to no
degranulation in untreated rat mesentery (Fig. S2). Close examination of lymphatic vessels in compound 48/80-treated
rats, such as the area proximal to the two degranulated MCs
shown in Fig. 3 (D and F), revealed that MC particles appear
frequently in the center of the vessel surrounded entirely by
staining for lymphatic markers. However, because the lymphatic vessels in these preparations are collapsed, it was not
possible to definitively demonstrate the presence of the particles within them, although it is unlikely that there is much
space outside the vessels given the extreme thinness of the
tissue (15–20 µm; Barber et al., 1987). So, to corroborate
these data with cross-sectioned patent lymphatic vessels, we
returned to the mouse footpad. Dilated lymphatics were frequently seen in this tissue 30 min after the injection of comJEM VOL. 206, October 26, 2009

pound 48/80. We clearly observed MC-derived particles on
the luminal side of the endothelium (Fig. 3 G; Videos 4 and 5
show 3D reconstructions of this area imaged with laserscanning confocal microscopy). DIC microscopy of the same
area revealed that the particle shown in Fig. 3 G was not
inside a migrating phagocyte but was apparently moving as a
free particle (Fig. S3). Together, these images suggest that
MC-derived particles can gain access to and traffic within the
lymphatic system.
Next, we sought to demonstrate that the MC particles
could reach DLNs from the periphery. Our initial attempts to
detect MC particles trafficking from footpads to DLNs was
confounded by the fact that the MC activator compound
48/80 that we had injected not only activated tissue resident
MCs but had also drained into the DLNs, causing degranulation of LN-resident MCs (Fig. 4 A). Therefore, we selectively
activated peripheral MCs in the skin by painting the footpads
with a solution PMA in acetone (Wershil et al., 1988). In
agreement with the literature, this treatment caused local
degranulation. Footpad MCs were intact after painting with
acetone alone. Next, we examined the DLNs to see if the
observed MC degranulation was selective to the site of application. In contrast to DLNs harvested 2 h after administration
of compound 48/80, where extensive degranulation of LN
MCs occurred (Fig. 4 A), the LN-resident MCs of mice after
PMA treatment (Fig. 4 C) appeared similar to vehicle alone
(Fig. 4 B), without apparent degranulation. Having confirmed
that the topical application of PMA selectively activated footpad MCs, we examined the DLNs more closely and observed
numerous metachromatic (heparin containing) particles in the
periphery of the same LN section shown in Fig. 4 C (Fig. 4 D).
The subcapsular and cortical sinuses, also at the edge of the
LN, are the first to receive peripheral lymph from afferent
lymphatics. A higher magnification of a selected area of the
DLN shows several individual particles (Fig. 4 E).
To support our conclusion that particles detected in the
DLNs originated from the periphery and to determine with
certainty that these particles could traffic from peripheral sites
to the DLN, we isolated particles from the peritoneal MCs of
mice. These particles were injected into the footpads of MC
deficient KitW-sh/W-sh mice. DLNs were isolated 45 min later
and cross sections were examined for the presence of granules
after toluidine blue staining. At this early time point, it was
extremely unlikely that the observed particles were delivered
to the LN inside migrating cells, as the processes involved in
migrating through tissues and across the lymphatic endothelium are complex and require changes in gene expression.
Distinct particles appeared to be widely distributed in the
cortical and medullary sinuses of the DLNs (Fig. 5, A and B).
A close-up showing a cluster of metachromatic particles in
the periphery of the DLN is shown in Fig. 5 C. To exclude
the possibility that particles of this size only enter lymphatic
vessels under conditions of nonphysiologic interstitial pressure (as a result of injection), we painted a footpad laceration
with a suspension of fluorescent microspheres with the same
size and surface charge characteristics of MC-derived particles.
2459

Figure 3. Extracellular MC granule particles enter lymphatic capillaries. (A) Mosaic of 40× confocal micrographs showing association of MCs and
lymphatic capillaries in whole mount rat mesentery preparation. Inset, 5× magnified view of (A). Green, LYVE-1; blue, MC heparin. Bar, 1 mm. (B) Fluorescence micrograph showing colocalization between released MC-derived particles and lymphatic capillaries 30 min after intraperitoneal injection of 500 µg of
compound 48/80. Green, LYVE-1; red, MC heparin. Bar, 25 µm. (C) Same area as in B, but only areas of colocalization are shown. (D–F) Confocal micrographs of MC granule particles inside a lymphatic capillary in rat mesentery whole mount 30 min after intraperitoneal injection of 500 µg of compound
48/80. D, anti-LYVE-1; E, avidin; F, overlay. Green, LYVE-1, blue, MC heparin. Bars, 20 µm. (G) Isosurface rendering of confocal volume from mouse footpad
section 30 min after injection of compound 48/80. Green, LYVE-1; blue, MC heparin. Bar, 8 µm. All images are representative of experiments repeated
independently at least twice. Three rats were used for intraperitoneal compound 48/80 studies, and several groups of two to three mice were used for
footpad compound 48/80 studies.
2460
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Microspheres were found in the DLN only 30 min later,
indicating that they entered lymphatic vessels and were delivered by lymph (Fig. S4). Collectively, these experiments
indicate that MC particles readily traffic to the DLNs via the
lymphatic system.
Particle-associated TNF elicits LN enlargement
Our hypothesis is that peripheral MCs are able to modulate
important physiological activities at distal sites through the
release of particles bearing critical mediators. Therefore, we
examined the effect of footpad injection of MC particles on
LN remodeling. To demonstrate the specific contribution of
TNF, we injected an equal number of particles isolated from
TNF/ mice in a parallel experiment. The LN hypertrophy
induced by granules from WT and TNF/ animals was
compared after 24 h to saline-injected controls. Although
MC particles from wild-type mice induced a twofold increase
in LN size, particles from TNF/ mice failed to trigger any
LN hypertrophy (Fig. 5 D). This finding not only demonstrates a functional role for MC-derived particles but also
demonstrates the specific role played by TNF bound within
them in modulating LN hypertrophy.

Another important component of our hypothesis is that
by being packaged within stable particles, MC mediators,
such as TNF, should be protected from dilution and degradation and that, therefore, minimal amounts will be required to
promote biological activity at their target sites. To test this
notion, we compared soluble recombinant TNF to TNF encapsulated within synthetic heparin/chitosan particles for
their ability to effect remodeling of DLNs. As mentioned
previously, heparin has a very high negative charge density.
Chitosan, in contrast, is a polycation at pH <5.5 because of
protonation of the amino groups in the side chains of the
polysaccharide. When solutions containing these compounds
are mixed, they rapidly phase separate to form spherical particles because of electrostatic interaction of the oppositely
charged heparin and chitosan. This same process, called polyelectrolyte complexation, is thought to be the mechanism by
which insoluble complexes are formed in MC granules, only
with highly basic MC proteases substituting for chitosan as
the polycation (Schwartz et al., 1981). The resulting particles
were similar in size to those purified from rat MCs (Fig. 6,
A and B). Because any molecules bound to heparin or chitosan
before the mixing can be packaged within, we encapsulated

Figure 4. Topical application of PMA activates only local MCs, allowing visualization of trafficked granules in the DLN. (A–C) Toludine blue–
stained sections of DLN tissue 2 h after injection with 32 µg of compound 48/80 (A), topical application of vehicle alone (B), or topical application of
10 µg PMA (C). (D and E) Free metachromatic granules could be visualized within the DLNs of PMA-treated footpads. E is the magnified view of the white
box in D. All panels show results that are representative of three independent experiments using groups of 2–3 mice each. Bars: (A–D) 50 µm; (E) 20 µm.
JEM VOL. 206, October 26, 2009
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recombinant TNF (rTNF) in synthetic particles by adding
the mediator to the heparin solution before complexation.
As shown in Fig. 6 C, the delivery of TNF in particle
form increased its potency for causing LN enlargement by
>10-fold. As the amount of TNF encapsulated was not directly
measured, the 1-ng dose shown assumes 100% encapsulation.
Other experiments performed during the development of
these particles suggest that the true level of encapsulation
using this protocol is almost never >30% (unpublished data),
indicating that the 10-fold difference in potency between
particle-delivered TNF and soluble TNF is a significant underestimate. In a separate experiment, we observed that even
as little as 16 pg of TNF could elicit LN hypertrophy when
delivered in particle form, supporting previous findings that
the early increases in DLN TNF reflect the movement of
a very small amount of cytokine (McLachlan et al., 2003).

In addition, microparticles fabricated in exactly the same way
except for the omission of TNF did not cause LN enlargement (Fig. 6 C), showing that TNF, and not the delivery
vehicle, was responsible for the observed effects. Likewise,
the injection of a mixture of the soluble components (combined under pH conditions under which no particles form)
was not adequate to elicit LN enlargement (Fig. 6 C). Collectively, these findings reveal that, when packaged within
particles of similar composition as MC particles, minimal
amounts of TNF applied in the periphery can induce significant remodeling of distal DLNs.
DISCUSSION
In conclusion, we have demonstrated the existence of a novel
form of extracellular communication over long distances. The
use of the circulatory system to deliver extracellular signals

Figure 5. Injected granules traffic to the DLN and contain functional TNF. (A) Toluidine blue staining of DLN tissue sections from an MC-deficient
KitW-sh/W-sh mouse injected with 9.0 × 103 isolated MC-derived particles. Bar, 50 µm. (B) Same area as in A showing only metachromatic staining. The location of the edge of the DLN is depicted by a dashed line. (C) Magnification from square in A. Bar, 10 µm. (D) LN hypertrophy 24 h after injection of 1.5 × 104
particles purified from WT or TNF/ mice (n = 3 for each group; *, P < 0.005 for the comparison between the two groups; data analyzed by unpaired twotailed Student’s t test; error bars indicate standard error of the mean). All panels show results that are representative of two independent experiments.
2462
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is well known, as endocrine signaling involves the transport
of hormones from their secreting cells to distant targets.
However, this has mainly been studied in the context of signals that reach easily measurable concentrations. Such hormones, such as insulin, are secreted in great quantities by

large populations of cells devoted to that purpose. This kind
of signaling is relatively untargeted, insofar as high enough
concentrations are reached in the circulation that the soluble
mediator can be detected easily by most cells in the body or
at least by a receptor-bearing subset. Endocrine signaling is

Figure 6. Encapsulation in heparin/chitosan particles greatly enhances the ability of recombinant TNF to effect popliteal LN enlargement
24 h after footpad injection. (A) DIC micrograph showing purified rat MC-derived particles. (B) Micrograph showing synthetic heparin/chitosan
microparticles. These micrographs are representative of more than three independent experiments. Bars, 10 µm. (C) Less than 1 ng rTNF encapsulated in
1.3 × 105 synthetic particles similar to MC granule particles elicits more LN enlargement than 10 ng of soluble TNF when injected into the footpads of
mice. Black bars, particles with and without encapsulated TNF; open bars, soluble TNF; hatched bar, soluble TNF mixed with soluble chitosan and heparin
(n = 3 for each group; *, P < 0.05 vs. 10 ng soluble TNF; **, P < 0.01 vs. particles without TNF, 1 ng soluble TNF, and 1 ng soluble TNF mixed with soluble
chitosan and heparin; data analyzed by one-way analysis of variance followed by Tukey’s Multiple Comparisons test; error bars indicate standard error of
the mean). Results shown are representative of two independent experiments.
JEM VOL. 206, October 26, 2009
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also important during immunological responses, for example,
the induction of the systemic acute phase response after initiation of inflammation (Suffredini et al., 1999).
This work suggests that there may exist a much less obvious, but equally important, parallel secondary system of long
distance inflammatory communication earlier in responses,
involving much lower levels of signals. Because most inflammatory signals are not very long lived, it is reasonable to expect
that adaptations must have developed to prolong the survival
of extracellular signals and to ensure their delivery to specific
targets. This kind of adaptation is already well known for
many blood-borne endocrine signals whose solubility and
targeting are regulated by serum carrier proteins (Bischoff
and Pilhorn, 1948; Gordon et al., 1952). The delivery of
TNF to DLNs during inflammation by MC-derived particles
appears to provide an example of such an adaptation. As opposed to the kind of untargeted signaling discussed previously, MC particles seem to be specialized for the delivery of
very small quantities of cargo from one specific site (the site
of inflammation) to another specific site (targets in the DLN
that can mediate changes favoring the development of adaptive immunity). Heparin, the predominant component of
MC particles, has the highest negative charge density of any
molecule known in mammalian biology, which likely minimizes interaction with adjacent cells and other structures in
the extracellular environment, with this charge favoring their
movement into the lymphatic drainage (Patel et al., 1984). In
contrast, their size (although likely retarding their movement
through peripheral tissues) would also prevent them from
moving through the DLN to the efferent lymph, resulting in
their sequestration in this target organ (Hirano and Hunt,
1985). This scenario is favored by our finding that packaging
TNF in similar heparin-based synthetic particles greatly
enhances its potency relative to soluble TNF.
Synchronization and collaboration between the periphery
and the draining secondary lymphoid tissue is crucial for a rapid
and effective host response to infection. DLN enlargement
alone can shorten the time between pathogen entry and antigen presentation by increasing the chances that the extremely
rare circulating lymphocytes carrying receptors for antigens
specific to the infection are present. The delivery of inflammatory signals by this unusual mechanism may help to explain
how this MC-dependent process occurs so rapidly given the
small amount of prestored cytokine available. It is also possible
that particle-associated molecules other than TNF might be
important in aspects of LN remodeling; MC proteases are
clearly present in large quantities, and other low-abundance
signaling molecules may also be present. For example, there is
some evidence that MCs also prestore fibroblast growth factor 2
(Qu et al., 1998) and vascular endothelial growth factor
(Grützkau et al., 1998), two well known heparin-binding
growth factors which could be involved in the regulation of
LN vascular remodeling during immune responses.
Although the work presented in this paper demonstrates
that MC-derived particles can deliver signals from the periphery to LNs, the disposition of such signals once they
2464

reach the node remains to be elucidated. The most obvious
target of peripheral TNF in the LN is the high endothelial
venule (HEV) endothelium, which controls the recruitment
of naive lymphocytes from the circulation into the node
(a critical determinant of LN size). The up-regulation of adhesion molecules here could enhance such recruitment, and that
does appear to be an aspect of MC-dependent LN enlargement (McLachlan et al., 2003). It is known that small soluble
molecules can reach this site from afferent lymph via conduits
that connect the sinus system to the HEV (Gretz et al., 2000).
The size of the MC particles precludes their entry into this
conduit system. We favor a mechanism by which cargo molecules are solubilized over time, essentially acting as slowrelease capsules allowing the persistence of the signal until it
has been carried most of the way to its target. Supporting this
notion, experiments performed during the development of
the synthetic microparticles described here showed that such
particles do release encapsulated TNF over the course of 24 h
(Fig. S5), suggesting that this may be the case. Alternatively,
the site of action may be in the sinus system, and an amplification step may be required before the signal can be propagated to the HEVs. It is also likely that processes other than
lymphocyte recruitment (such as prevention of lymphocyte
egress) are also affected.
It is interesting to speculate that this process also occurs in
human biology, where the distances between peripheral sites
of infection or inflammation and draining secondary lymphoid tissue are even greater, presumably increasing the
necessity of an adaptation such as the one described in this
paper. Although there are substantial differences between human
and rodent MCs, human MCs do contain preformed TNF
(Walsh et al., 1991; Frangogiannis et al., 1998). There is also
significant evidence to suggest that human MCs also release
insoluble granule contents during degranulation (Kobayasi
and Asboe-Hansen, 1969; Murphy et al., 1987; Caulfield
et al., 1990; Kaminer et al., 1991; Lee and Vijayasingam,
1995; Akimoto et al., 1998). Given these factors, it is probable that a similar system operates in human immunology.
MCs reside at the crossroads between the external environment, the blood vasculature, and the lymphatic system.
They are ideally situated to orchestrate events during the earliest stages of immune responses, and it seems likely that this
is their physiological role in mammalian biology. In fact, their
proximity to these critical structures suggests that they influence them directly in many ways in addition to those that
have already been described. This work indicates one way in
which these important cells may also influence events in distant
lymphoid tissues.
Finally, many other immune cells including neutrophils
(Niemann et al., 2007), eosinophils (Erjefält et al., 1999), basophils (Metcalfe et al., 1984), and cytotoxic T lymphocytes
(Masson et al., 1990) store biologically active compounds in
granules. The granular matrix in these cell types is comprised
of serglycin proteoglycans, which, in addition to their role in
storage, can contribute to the extracellular function of the
bound mediators (Veugelers et al., 2004). To date, only the
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local effects of such complexes have been investigated. Our
studies suggest that they may also be specialized to deliver
their cargo of signaling proteins to far more distant targets.
MATERIALS AND METHODS
Animal studies. Rat peritoneal MCs were obtained by pooling peritoneal
and pleural lavage from Sprague-Dawley rats (Taconic). For compound
48/80 treatment to induce degranulation of mesenteric MCs, rats were injected intraperitoneally with 0.5 mg compound 48/80 in 10 ml PBS.
C57BL/6 mice obtained from NCI were used for most mouse experiments. Single footpad injections were done in a volume of 20 µl of vehicle
in most cases. For the LN enlargement experiment, animals were injected on
one side with the test substance and with vehicle on the other side to allow
for within-animal controls for baseline variations in LN size.
For in vivo tracking studies, 10 µg PMA (Sigma-Aldrich) at 1 µg/µl in
acetone or acetone alone were applied in two sequential treatments to the
footpads of mice anesthetized with pentobarbital. Footpads were allowed to
dry completely between applications. DLNs and footpads were harvested
after 2 h.
For the isolation of mouse MC-derived particles, peritoneal lavage was
performed on two to three mice using DME, and isolated cell suspensions
were pooled and stimulated by 1 µM ionomycin (Sigma-Aldrich). Treatment with ionomycin was followed by incubation for 15 min in a cell culture incubator, after which the cellular fraction was removed by two rounds
of centrifugation at 500 g for 5 min. Exocytosed particles were then pelleted
by spinning at 12,000 g for 10 min at 4°C. Particles were washed and resuspended in PBS for injection and quantification using a hemocytometer. Injections were performed with a 10-µl volume. For DLN hypertrophy studies,
DLN mass was determined after 24 h as compared with a paired saline control. The saline control for DLN hypertrophy studies using isolated granules
contained 5% DME to control for any residual media in the preparation. For
tracking studies, KitW-sh/W-sh mice (from our breeding colony) were injected
with isolated particles and DLNs were recovered 45 min after particle injection for sectioning and staining with toluidine blue. Images of metachromatic areas were generated using Photoshop (Adobe). All animal experiments
were done according to protocols approved by the Duke University Division of Laboratory Animal Resources and the Duke University Institutional
Animal Care and Use Committee.
Cell culture. For the generation of TNF-GFP–expressing cells, total RNA
was isolated from BMMCs using an RNeasy kit (QIAGEN). Complementary DNA was made using the iScript cDNA synthesis kit (Bio-Rad Laboratories). The tnf gene was PCR amplified using the following primers: tnf
forward, 5-GATCTCGAGATGAGCACAGAAAGCATGATCCG-3;
and tnf reverse, 5-GGTGGATCCCGCAGAGCAATGACTCCAAAGTAG-3. The PCR product was digested with XhoI–BamHI, and then
ligated with XhoI–BamHI-digested pLEGFP-N1 (BD) to generate
pTNF-GFP. Sequence accuracy and whether TNF and GFP genes were in
frame were confirmed by sequencing. The production of infectious viral
particles and transfection of RBL-2H3 cell line and BMMCs were done as
recommended by the vendor (Retroviral Gene Transfer and Expression
User Manual; BD). In brief, the packaging cell line GP2-293 cells were
transfected with pVSV-G (BD) and pTNF-GFP using lipofectamine 2000
(Invitrogen). Between 48 and 72 h after transfection, viral particles were
collected. Healthy RBL-2H3 cells were grown to 50% confluence and then
infected by collected viral particles. The infection rate of RBL-2H3 cells was
80–90%. BMMCs were cultured in the presence of 5 ng/ml rIL-3 (R&D
Systems) and 5 ng/ml rSCF (R&D Systems). 2 × 105 cells/ml of healthy and
actively dividing BMMCs were infected by the viral particles. The infection
rate of BMMCs was around 5–10% because of the fact that these cells grow
slowly and in suspension. The TNF-GFP–transfected cells were selected by
adding Geneticin (Invitrogen) to a final concentration of 250 µg/ml for 5 d.
TNF-GFP–expressing BMMCs were cultured in 5 ng/ml rIL-3 on a monolayer of 3T3 fibroblasts for 10 d before treatment. Both TNF-GFP–expressing
cell types were observed after activation with 1 µM ionomycin.
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Microscopy. Whole mount rat mesentery preparations were made by
stretching a loop of bowel over a slide so that the transparent windows were
spread across them, waiting for these to dry, and then cutting away unwanted tissue. Then they were fixed with cold acetone, permeabilized, and
blocked overnight in PBS with 0.3% Triton X-100 and 5% goat serum, and
labeled with an anti–LYVE-1 antibody (Millipore) and fluorophore (Alexa
Fluor 488 or TRITC, depending on the experiment)-labeled avidin (SigmaAldrich) before imaging using a laser-scanning confocal microscope. The
LYVE-1 antibody was detected with an FITC-conjugated anti–rabbit IgG
F(ab)2 (Jackson ImmunoResearch Laboratories). Some images were made
under epifluorescence illumination.
For sections, 10-µm frozen sections were made and fixed in cold acetone before being blocked in PBS with 1% BSA and subsequently labeled
with the reagents described in the previous paragraph. For toluidine blue
staining, frozen sections were rapidly fixed in 75% methanol, 20% formaldehyde, and 5% acetic acid and then stained in acidic 0.1% toluidine blue and
cover slipped.
To create the image showing only metachromatic areas of toluidine
blue–stained LN sections, the original image was transformed in Photoshop
using the select color range function and visually identifying areas that corresponded to the metachromatic particles. Photoshop was then used to generate an image depicting only those areas, which were verified visually by
comparing the original image to the generated image. This program was not
used to identify particles but rather to produce an outline of metachromatic
areas with more visual contrast for viewing in journal format.
For SEM, rat peritoneal lavage cells were seeded onto polylysine-coated
coverslips in RPMI 1640 media with 10% FBS and incubated for 15 min at
37°C. They were then treated with compound 48/80 at 5 µg/ml for 15 min.
Finally, the cells were fixed in 3% glutaraldehyde and processed for SEM.
Coverslips were postfixed for one hour in 1% OsO4 (in water) before being
dehydrated into ethanol and hexamethyldisilazane and finally dried. Then
they were mounted and coated with osmium for imaging on a microscope
(XL-30 ESEM-FEG; FEI Company).
Immunoblotting. For the purification of MC granule particles, rat peritoneal cells were treated for 5 min with 5 µg/ml of compound 48/80 in a cell
culture incubator. After the treatment, the cells were separated from granule
particles by centrifugation at 450 g. The supernatant was carefully removed
and thereafter spun at 12,000 g for 10 min at 4°C to pellet MC-derived particles. These were then solubilized by boiling in Laemmli buffer under reducing conditions, separating the proteins by SDS-PAGE, and transferring
to a PDVF membrane. The membrane was blocked for 1 h in 5% milk in
TBST and then probed with an anti-TNF antibody (Santa Cruz Biotechnology, Inc.) at 200 ng/ml at 4°C overnight. The signal was detected using enhanced chemiluminescence.
Microparticles. Synthetic heparin/chitosan particles were generated by
gradually combining 1% heparin (EMD) and 1% chitosan (Primex; both in
distilled H2O) in a 1:1 ratio at approximately pH 5. To produce particles, 1 vol
of 1% chitosan was added to 5 vol of 1% heparin and vortexed for 30 s. This
was repeated until a 1:1 ratio of 1% chitosan to 1% heparin was achieved.
After 10 min at room temperature, the pH was then adjusted to neutrality to
prevent further aggregation. Particles were centrifuged at 14,000 g for 10 min
at 4°C to form a pellet and washed with water before resuspension in PBS
for injections or water for visualization on coverslips. To load particles with
TNF, 5 ng rTNF (R&D Systems) was vortexed for 10 min in 1.25 ml 1%
heparin before the addition of chitosan as described in this section.
Online supplemental material. Fig. S1 shows that TNF-GFP fusion protein colocalizes with granule markers in RBL-2H3 cells. Fig. S2 shows intact
MCs in untreated rat mesentery. Fig. S3 shows that intralymphatic MC-derived
particle is not inside a migratory phagocyte. Fig. S4 shows that particles the
size of MC-derived particles can enter lymphatics and rapidly reach the DLN
under physiological conditions. Fig. S5 shows that recombinant TNF is
gradually released from heparin-based microparticles. Video 1 shows DIC
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video microscopy of compound 48/80-activated rat peritoneal MCs releasing granule particles. Video 2 shows green fluorescent/DIC overlay video of
ionomycin-activated TNF-GFP–expressing RBL-2H3 cells. Video 3 shows
green fluorescent/DIC overlay video of ionomycin-activated TNF-GFP–
expressing 3T3 fibroblast-cocultured BMMCs. Video 4 shows three-dimensional reconstruction of laser-scanning confocal data showing MC-derived
particles inside a dermal lymphatic vessel of compound 48/80-injected
mouse rear footpad. Video 5 shows isosurface reconstruction of the same region shown in Video 4. Online supplemental material is available at http://
www.jem.org/cgi/content/full/jem.20090805/DC1.
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